C01B32/23

ROOM TEMPERATURE UV-ACTIVATED HYDROGEN GAS SENSOR

A hydrogen sensor that efficiently detects hydrogen gas at room temperature comprising a gold decorated reduced graphene oxide/zinc oxide (Au/rGO/ZnO) heterostructured composite, methods for making this sensor and a method for sensitive room temperature detection of hydrogen using the sensor.

Large scale oxidized graphene production for industrial applications

Existing methods of producing high quality graphene/graphite oxides are generally accomplished by exfoliating graphite into flakes and oxidizing the graphite flakes with strong oxidizers under extreme conditions and require careful purification. The oxidizers are typically strong acids used in high concentrations at elevated temperatures requiring complicated purification processes to yield oxidized graphene/sheets. The existing processes can cost up to $12,000/gram. This invention uses a mild oxidant combined with mechanical processing where the sole products are oxidized graphite/graphene and water without the need for further purification.

Large scale oxidized graphene production for industrial applications

Existing methods of producing high quality graphene/graphite oxides are generally accomplished by exfoliating graphite into flakes and oxidizing the graphite flakes with strong oxidizers under extreme conditions and require careful purification. The oxidizers are typically strong acids used in high concentrations at elevated temperatures requiring complicated purification processes to yield oxidized graphene/sheets. The existing processes can cost up to $12,000/gram. This invention uses a mild oxidant combined with mechanical processing where the sole products are oxidized graphite/graphene and water without the need for further purification.

Process for producing graphene oxide products and uses thereof

Provided is a process for producing graphene oxide (GO) product including forming a reaction mixture including graphite-based precursor and an oxidizing effective amount of an oxygenation agent including a complex of hypofluorous acid (HOF) and an organic solvent (HOF.organic solvent) and mixing the reaction mixture for a time sufficient to cause oxidation of the graphite based precursor. Further provided are products including the GO obtainable by the process or graphene products obtainable therefrom, as well as articles of manufacture including the same.

Process for producing graphene oxide products and uses thereof

Provided is a process for producing graphene oxide (GO) product including forming a reaction mixture including graphite-based precursor and an oxidizing effective amount of an oxygenation agent including a complex of hypofluorous acid (HOF) and an organic solvent (HOF.organic solvent) and mixing the reaction mixture for a time sufficient to cause oxidation of the graphite based precursor. Further provided are products including the GO obtainable by the process or graphene products obtainable therefrom, as well as articles of manufacture including the same.

Graphene compound, method for forming graphene compound, and lithium-ion storage battery

A material that can be used in a wide temperature range is provided. A graphene compound includes graphene or graphene oxide and a substituted or unsubstituted chain group, the chain group includes two or more ether bonds, and the chain group is bonded to the above graphene or graphene oxide through a Si atom. Alternatively, a method for forming a graphene compound includes a first step and a second step after the first step. In the first step, graphene oxide and a base are stirred under a nitrogen stream. In the second step, the mixture is cooled to room temperature, a silylating agent that has a group having two or more ether bonds is introduced into the mixture, and the obtained mixture is stirred. The base is butylamine, pentylamine, hexylamine, diethylamine, dipropylamine, dibutylamine, triethylamine, tripropylamine, or pyridine.

Graphene compound, method for forming graphene compound, and lithium-ion storage battery

A material that can be used in a wide temperature range is provided. A graphene compound includes graphene or graphene oxide and a substituted or unsubstituted chain group, the chain group includes two or more ether bonds, and the chain group is bonded to the above graphene or graphene oxide through a Si atom. Alternatively, a method for forming a graphene compound includes a first step and a second step after the first step. In the first step, graphene oxide and a base are stirred under a nitrogen stream. In the second step, the mixture is cooled to room temperature, a silylating agent that has a group having two or more ether bonds is introduced into the mixture, and the obtained mixture is stirred. The base is butylamine, pentylamine, hexylamine, diethylamine, dipropylamine, dibutylamine, triethylamine, tripropylamine, or pyridine.

A Method for the Manufacture of Graphene Oxide from Kish Graphite
20210094829 · 2021-04-01 ·

The present invention provides a method for the manufacture of graphene oxide from Kish graphite.

A Method for the Manufacture of Graphene Oxide from Kish Graphite
20210094829 · 2021-04-01 ·

The present invention provides a method for the manufacture of graphene oxide from Kish graphite.

Nanoparticle compositions and methods of making and using the same

Water soluble graphene oxide nanoparticles (GO) are provided having graphene sheets containing carboxylic and hydroxyl groups. The diameter of the GO when present in a closed form ranges from about 40 nm to 120 nm. Eco-friendly methods are provided for producing the GO. Methods for reversible encapsulation of a molecule within water soluble carbon nanoparticles (wsCNP) including the GO nanoparticles are provided that allow for delivery of the wsCNP loaded with therapeutic and/or imaging agents to a subject in need by releasing the therapeutic/imaging agent upon an increase in pH above about 7.2. The wsCNP have been shown to cross the blood brain barrier in a mouse model of vascular dementia, and methods are provided for delivering the wsCNP loaded with a therapeutic and/or imaging molecule to the brain.